| 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|
| Gross margin | 80,0 k € | +15.9% | 69,0 k € | +141.2% | 28,6 k € | +5.9% | 27,0 k € | |
| EBITDA | 78,8 k € | +14.2% | 69,0 k € | +142.3% | 28,5 k € | +6.9% | 26,7 k € | |
| Operating profit | 78,8 k € | +14.2% | 69,0 k € | +142.3% | 28,5 k € | +8.8% | 26,2 k € | |
| Profit/loss | 57,6 k € | +14.0% | 50,6 k € | +173.9% | 18,5 k € | +10.5% | 16,7 k € | |
| Equity | 2,1 k € | -61.5% | 5,5 k € | +7175.3% | -77,6 € | -103.9% | 2,0 k € | |
| Total assets | 321,3 k € | +6.1% | 302,9 k € | +22.5% | 247,3 k € | +3.0% | 240,2 k € | |
| Cash | 167,0 k € | +2.3% | 163,2 k € | +36.2% | 119,8 k € | -25.2% | 160,2 k € | |
| Debts | 255,2 k € | -11.7% | 289,1 k € | +22.1% | 236,8 k € | +0.1% | 236,6 k € | |
Private limited company · Deinze · incorporated on 20/11/2020
Private limited company profitable but thinly capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure — thin equity (2,1 k €) relative to earnings. The abridged model hides revenue.
Dierenartsen Hond en Kat is a Private limited company incorporated in 2020. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Deinze.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.